正子斷層掃描 (PET) 市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 產業預測，2024-2031年

2022年全球正子斷層掃描（PET）市場規模為23.5億美元，在預測期內從2023年的25.2億美元成長到2031年的42.1億美元，預計在預測期內（2024-2031年）年複合成長率為6.61%。

癌症和阿茲海默症等危及生命的疾病的盛行率不斷上升，大幅推動了對 PET 掃描的需求，這對於支持診斷和持續患者照護的先進成像技術非常重要。這些掃描提供了對體內生理和代謝過程的重要洞察，使醫療保健專業人員能夠有效評估和管理慢性疾病，並最終改善患者的治療效果和治療效果。隨著慢性病數量持續增加，對標靶治療和個人化醫療的需求不斷增加，使得 PET 掃描在根據患者的獨特需求量身定做治療方面具有不可估量的價值。由於分子成像技術的進步以及人工智慧（AI）和機器學習的結合提高了掃描的準確性和效率，這些成像技術已經發展到能夠準確測量疾病進展和治療反應。這些技術進步不僅將有助於更佳識別和追蹤疾病狀態，還將擴大 PET 掃描在各個醫學專業的研究和臨床診斷中的作用。因此，PET 掃描市場經歷強勁成長，反映出 PET 掃描在現代醫療保健中的重要作用以及更個人化醫療方法的推動力。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 依細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 課題
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 價值鏈分析
• 供應鏈分析
• 專利分析
• 貿易分析
• 技術分析
• 監管環境
• 案例研究分析

正子斷層掃描市場：依產品

• 市場概況
• 獨立 PET 系統
• PET/CT系統
  • 低切掃描儀
  • 中切掃描儀
  • 高切掃描儀
• PET/MRI系統

正子斷層掃描市場：依應用分類

• 市場概況
• 腫瘤學
• 神經病學
• 心血管
• 其他用途

正子斷層掃描市場：依最終用戶分類

• 市場概況
• 醫院和外科中心
• 診斷和影像診所
• 門診治療中心
• 其他最終用戶

正子斷層掃描市場：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲（MEA）
  • 海灣合作理事會國家
  • 南非
  • 其他中東、非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• General Electric
• Koninklijke Philips NV
• Siemens AG
• Shanghai United Imaging Healthcare Co., Ltd
• Canon Inc.
• Shimadzu Corporation
• Mediso Ltd.
• MinFound Medical Systems Co., Ltd
• Neusoft Corporation
• Bruker
• CMR Naviscan
• Kindsway Biotech
• Hermes Medical Solutions
• Sofie Biosciences
• Prescient Medical Imaging
• Reflexion
• Cubresa Inc.
• Synchropet, Inc.
• Novartis
• Revvity Inc.

Global Positron Emission Tomography Market size was valued at USD 2.35 billion in 2022 and is poised to grow from USD 2.52 billion in 2023 to USD 4.21 billion by 2031, growing at a CAGR of 6.61% during the forecast period (2024-2031).

The rising prevalence of life-threatening conditions like cancer and Alzheimer's disease has significantly fueled the demand for PET scans, which are essential for advanced imaging technologies that aid in diagnosis and ongoing patient care. These scans provide crucial insights into the physiological and metabolic processes within the body, enabling healthcare professionals to effectively assess and manage chronic conditions, ultimately improving patient outcomes and treatment success. As chronic illnesses continue to rise, there is an increasing need for targeted therapeutics and personalized medicine, making PET scans invaluable for tailoring treatments to unique patient needs. These imaging techniques have evolved to measure disease progression and therapeutic responses accurately, thanks to advancements in molecular imaging technology and the incorporation of artificial intelligence (AI) and machine learning, which enhance the precision and efficiency of scans. This technological evolution not only facilitates better identification and follow-up of medical conditions but also expands the role of PET scans in both research and clinical diagnostics across various medical specialties. Consequently, the market for PET scans is experiencing robust growth, reflecting their integral role in contemporary healthcare and the drive towards more personalized medical approaches.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Positron Emission Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Positron Emission Tomography Market Segmental Analysis

Global Positron Emission Tomography Market is segmented by Product, Application, End User, and Region. Based on Product, the market is segmented into Standalone PET Systems, PET/CT Systems (Low-Slice Scanners, Medium-Slice Scanners, High-Slice Scanners), PET/MRI Systems. Based on Application, the market is segmented into Oncology Applications, Neurological Applications, Cardiovascular Applications, Other Applications. Based on End User, the market is segmented into Hospitals & Surgical Centers, Diagnostic & Imaging Clinics, Ambulatory Care Centers, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Positron Emission Tomography Market

The escalating incidence of chronic diseases, including cancer, Alzheimer's disease, and cardiovascular disorders, serves as a pivotal market driver for the Global Positron Emission Tomography (PET) market. As these conditions necessitate sophisticated imaging techniques for effective diagnosis and ongoing management, PET scans have become vital tools in the healthcare arsenal. They provide critical insights into metabolic and physiological functions, which are essential for formulating tailored treatment plans. The burgeoning patient population suffering from chronic illnesses worldwide enhances the demand for PET technology, thereby propelling market growth. This trend underscores the need for advanced diagnostic modalities to effectively navigate the complexities of chronic disease management.

Restraints in the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market faces significant restraints primarily due to the prohibitive costs associated with PET scanners. High purchase prices, coupled with substantial operational and maintenance expenses, pose hurdles for smaller medical facilities and diagnostic laboratories with limited budgets. This financial barrier restricts access to advanced imaging technologies, particularly in resource-constrained environments. As a result, the high costs hinder broader adoption and utilization of PET scanning services, ultimately stifling market growth and limiting the expansion of innovative applications that could enhance diagnostic capabilities and improve patient outcomes in the healthcare sector.

Market Trends of the Global Positron Emission Tomography Market

The Global Positron Emission Tomography (PET) market is experiencing significant growth driven by the integration of machine learning and artificial intelligence into scanning technologies. These advancements enhance image capture, reconstruction, and analysis, leading to improved diagnostic accuracy and expedited procedures. AI algorithms facilitate the detection of subtle anomalies and ensure precise tumor characterization, which translates into faster and more effective patient care. Furthermore, the utilization of machine learning to predict patient outcomes facilitates personalized treatment plans based on imaging data. As these technologies evolve, their incorporation into PET systems is poised to transform clinical and research practices, driving market expansion and accessibility.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Supply Chain Analysis
• Patent Analysis
• Trade Analysis
• Technology Analysis
• Regulatory Landscape
• Case Study Analysis

Positron Emission Tomography Market, By Product

• Market Overview
• Standalone PET Systems
• PET/CT Systems
  • Low-Slice Scanners
  • Medium-Slice Scanners
  • High-Slice Scanners
• PET/MRI Systems

Positron Emission Tomography Market, By Application

• Market Overview
• Oncology Applications
• Neurological Applications
• Cardiovascular Applications
• Other Applications

Positron Emission Tomography Market, By End User

• Market Overview
• Hospitals And Surgical Centers
• Diagnostic And Imaging Clinics
• Ambulatory Care Centers
• Other End Users

Positron Emission Tomography Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai United Imaging Healthcare Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MinFound Medical Systems Co., Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kindsway Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hermes Medical Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sofie Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prescient Medical Imaging
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reflexion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cubresa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchropet, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments